Truist Maintains Labcorp at Buy, Raises Price Target to $395
Truist Securities maintained its Buy rating on Labcorp Holdings and raised its price target to $395 from $365.
Story updates
03:19:35 PM UTC
SquawkNews
Labcorp Holdings Price Target Raised to $395.00/Share From $365.00 by Truist Securities